Concepedia

Author

Hitoshi Kuwata

Kansai Electric Power Hospital

Also Known As

H. Kuwata, HITOSHI KUWATA, Hitoshi KUWATA, Hitoshi Kuwata, Kuwata, Hitoshi, Yusuke Seino

101

Publications

966

Citations

17

H-Index

53

Concepts

All Affiliations

Kansai Electric Power HospitalKansai Electric Power (Japan)Kobe UniversityGifu UniversityFujita Health University
HK

About

Hitoshi Kuwata is an author at Kansai Electric Power Hospital specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

82

2

Engineering

3

3

44

3

Health Sciences

2

2

50

4

Social Sciences

1

1

10

5

Cell Biology

1

1

13

Hitoshi Kuwata

×

24

Publications

654

Citations

16

H-Index

YearCitations

Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial

Hitoshi Kuwata, Masahiro Iwasaki, Shinobu Shimizu,

Diabetologia

2015

99

Sodium‐glucose co‐transporter‐2 inhibitor use and dietary carbohydrate intake in <scp>J</scp> apanese individuals with type 2 diabetes: <scp>A</scp> randomized, open‐label, 3‐arm parallel comparative, exploratory study

Daisuke Yabe, Masahiro Iwasaki, Hitoshi Kuwata,

Diabetes Obesity and Metabolism

2016

67

Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes

Daisuke Yabe, Koin Watanabe, Kenji Sugawara,

Journal of Diabetes Investigation

2011

63

Effects of glucagon‐like peptide‐1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study

Hitoshi Kuwata, Daisuke Yabe, Kenta Murotani,

Journal of Diabetes Investigation

2021

38

Lifestyle changes as a result of COVID‐19 containment measures: Bodyweight and glycemic control in patients with diabetes in the Japanese declaration of a state of emergency

Nagaaki Tanaka, Yoshiyuki Hamamoto, Yuri Kurotobi,

Journal of Diabetes Investigation

2021

37

Predicting efficacy of dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels

Masahiro Iwasaki, Fuminori Hoshian, Tomoko Tsuji,

Journal of Diabetes Investigation

2012

34

Retrospective analysis of safety and efficacy of insulin‐to‐liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β‐cell function

Ryota Usui, Daisuke Yabe, Hitoshi Kuwata,

Journal of Diabetes Investigation

2013

33

Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β‐cell function and the achievement of the glycated hemoglobin target 1 year after initiation

Ryota Usui, Yui Sakuramachi, Yusuke Seino,

Journal of Diabetes Investigation

2017

29

Use of the Japanese health insurance claims database to assess the risk of acute pancreatitis in patients with diabetes: comparison of <scp>DPP</scp> ‐4 inhibitors with other oral antidiabetic drugs

Daisuke Yabe, Hitoshi Kuwata, Makiko Kaneko,

Diabetes Obesity and Metabolism

2014

28

Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation

Ryota Usui, Daisuke Yabe, Hitoshi Kuwata,

Journal of Diabetes and its Complications

2015

27

Page 1